drugset
drugset / Trial / NCT03783988

Study With a Topical Gel Containing TRIAC and DHEA in Subjects With Skin Atrophy Due to Glucocorticoids

NCT03783988 ↗

Phase 1 Unknown 10 enrolled Trophea Development AB Uppsala University · collab
NaSingle-groupOpen-labelTreatment

Summary

An open, uncontrolled pharmacokinetic study with a new topical combination gel containing triiodothyroacetic acid (TRIAC) and dehydroepiandrosterone (DHEA) in subjects with skin atrophy due to topical treatment with glucocorticoids.

Timeline

Start
2019-01-15
Primary completion
2019-06
Completion
2019-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Dehydroepiandrosterone Other / unclassified — —
Subject Tiratricol Small molecule — —

Indications

skin atrophy